Literature DB >> 7493292

Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 495 patients with chronic hepatitis C.

P Pontisso1, M G Ruvoletto, M Nicoletti, S Tisminetzky, M Gerotto, M Levrero, M Artini, M Baldi, G Ballardini, L Barbara.   

Abstract

Different genotypes of hepatitis C virus (HCV) have been shown to have distinct geographical distribution and to associate with variable clinical features. To evaluate their role in chronic hepatitis in Italian patients, we studied 495 consecutive cases with chronic hepatitis C seen in nine sentinel centres homogeneously distributed over Italy. HCV genotyping was carried out using a dot-blot hybridization assay with genotype-specific probes. Four hundred and eleven patients were viraemic and could be evaluated: 57% were found to be infected with HCV-1, 31% with HCV-2, 8% with HCV-3, 1% showed mixed infection and 3% were ascribed to HCV-2b or HCV-4 by direct sequencing. Geographical distribution showed discrete territorial variations. A history of drug addiction was commoner in patients infected with HCV-3. There were no significant differences in activity of liver disease among different HCV genotypes but the response to interferon therapy was reduced in patients infected with HCV-1 compared to HCV-2 or HCV-3.

Entities:  

Mesh:

Year:  1995        PMID: 7493292     DOI: 10.1111/j.1365-2893.1995.tb00069.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy.

Authors:  P Dentico; N Curatolo; R Sacco; M De Luca; A Volpe; C Ranieri; C Genchi; L Petracca; R Buongiorno
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

2.  Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients.

Authors:  M G Rumi; F De Filippi; C La Vecchia; M F Donato; S Gallus; E Del Ninno; M Colombo
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases.

Authors:  G Montalto; A L Zignego; M I Ruggeri; C Giannini; M Soresi; M Monti; A Carroccio; G Careccia; D Di Martino; F Giannelli
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

4.  Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.

Authors:  S Bellentani; G Pozzato; G Saccoccio; M Crovatto; L S Crocè; L Mazzoran; F Masutti; G Cristianini; C Tiribelli
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

5.  Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

Authors:  L De Moliner; P Pontisso; G L De Salvo; L Cavalletto; L Chemello; A Alberti
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

6.  Acetylcysteine therapy for chronic hepatitis C: are its effects synergistic with interferon alpha? A pilot study.

Authors:  S Tripi; G D Gaetano; M Soresi; A Carroccio; G Bonfissuto; A Savi; O Vuturo; G Montalto
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

7.  Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Aghnaya A Dau
Journal:  BMC Res Notes       Date:  2015-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.